BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22753734)

  • 1. Role of melatonin in cancer treatment.
    Cutando A; López-Valverde A; Arias-Santiago S; DE Vicente J; DE Diego RG
    Anticancer Res; 2012 Jul; 32(7):2747-53. PubMed ID: 22753734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin: a multitasking molecule.
    Reiter RJ; Tan DX; Fuentes-Broto L
    Prog Brain Res; 2010; 181():127-51. PubMed ID: 20478436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a role for melatonin in supportive care?
    Lissoni P
    Support Care Cancer; 2002 Mar; 10(2):110-6. PubMed ID: 11862501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of melatonin in malignant diseases].
    Bartsch C; Bartsch H
    Wien Klin Wochenschr; 1997 Oct; 109(18):722-9. PubMed ID: 9441515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin in clinical oncology.
    Bartsch C; Bartsch H; Karasek M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():30-8. PubMed ID: 12019349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin in cancer management: progress and promise.
    Jung B; Ahmad N
    Cancer Res; 2006 Oct; 66(20):9789-93. PubMed ID: 17047036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin and mammary pathological growth.
    Cos S; Sánchez-Barceló EJ
    Front Neuroendocrinol; 2000 Apr; 21(2):133-70. PubMed ID: 10764528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms.
    Lissoni P
    Pathol Biol (Paris); 2007; 55(3-4):201-4. PubMed ID: 17446010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melatonin: adjuvant therapy of malignant tumors.
    Dziegiel P; Podhorska-Okolow M; Zabel M
    Med Sci Monit; 2008 May; 14(5):RA64-70. PubMed ID: 18443563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin.
    Hill SM; Cheng C; Yuan L; Mao L; Jockers R; Dauchy B; Frasch T; Blask DE
    Breast Cancer Res Treat; 2011 May; 127(1):91-8. PubMed ID: 20549340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pineal gland, melatonin and cancer. NEL Review.
    Karasek M; Pawlikowski M
    Neuro Endocrinol Lett; 1999; 20(3-4):139-144. PubMed ID: 11462104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer neuroimmunomodulation by pineal hormones other than melatonin: preliminary phase II study of the pineal indole 5-methoxytryptophol in association with low-dose IL-2 and melatonin.
    Lissoni P; Fumagalli L; Paolorossi F; Rovelli F; Roselli MG; Maestroni GJ
    J Biol Regul Homeost Agents; 1997; 11(3):119-22. PubMed ID: 9498162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Melatonin replacement therapy" for postmenopausal women: is it justified?
    Brzezinski A
    Menopause; 1998; 5(1):60-4. PubMed ID: 9689196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimmunomodulation in medical oncology: application of psychoneuroimmunology with subcutaneous low-dose IL-2 and the pineal hormone melatonin in patients with untreatable metastatic solid tumors.
    Lissoni P; Brivio F; Fumagalli L; Messina G; Vigoré L; Parolini D; Colciago M; Rovelli F
    Anticancer Res; 2008; 28(2B):1377-81. PubMed ID: 18505083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic actions of melatonin in cancer: possible mechanisms.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin as biological response modifier in cancer patients.
    Neri B; de Leonardis V; Gemelli MT; di Loro F; Mottola A; Ponchietti R; Raugei A; Cini G
    Anticancer Res; 1998; 18(2B):1329-32. PubMed ID: 9615811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobiological effects of melatonin as related to cancer.
    Hoang BX; Shaw DG; Pham PT; Levine SA
    Eur J Cancer Prev; 2007 Dec; 16(6):511-6. PubMed ID: 18090123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events.
    Blask DE; Sauer LA; Dauchy RT; Holowachuk EW; Ruhoff MS; Kopff HS
    Cancer Res; 1999 Sep; 59(18):4693-701. PubMed ID: 10493527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal expression of clock genes in pineal gland and brain and plasma levels of melatonin and cortisol in Atlantic salmon parr and smolts.
    Huang TS; Ruoff P; Fjelldal PG
    Chronobiol Int; 2010 Oct; 27(9-10):1697-714. PubMed ID: 20969518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian regulation of bird song, call, and locomotor behavior by pineal melatonin in the zebra finch.
    Wang G; Harpole CE; Trivedi AK; Cassone VM
    J Biol Rhythms; 2012 Apr; 27(2):145-55. PubMed ID: 22476775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.